Sopherion Therapeutics
Latest round
- Series C
Last raised
- Feb 2009
Total raised
- $128M
Investors
- 11
About Sopherion Therapeutics
Sopherion Therapeutics is a privately held biopharmaceutical company headquartered in Princeton, New Jersey. It develops and commercializes anti-cancer agents.
Who invested in Sopherion Therapeutics
11 investors across 3 rounds
See all investors in Sopherion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sopherion Therapeutics
Who invested in Sopherion Therapeutics?
Sopherion Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sopherion Therapeutics raised?
Sopherion Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sopherion Therapeutics last raise money?
Sopherion Therapeutics's most recent round on record is a Series C, in Feb 2009.
What does Sopherion Therapeutics do?
Sopherion Therapeutics is a privately held biopharmaceutical company headquartered in Princeton, New Jersey.
Where is Sopherion Therapeutics headquartered?
Sopherion Therapeutics is headquartered in Princeton, US.
Which VCs invest in companies like Sopherion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sopherion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Sopherion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.